Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (iNHL)

NCT03105336 is registered in ClinicalTrials.gov with Kite, A Gilead Company as lead sponsor.

NCT NCT03105336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03105336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (iNHL)
Lead sponsor
Kite, A Gilead Company
Phase
Phase 2
Overall status
Completed
Start date
June 6, 2017
Completion date
December 20, 2024
Enrollment
159 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma, indolent non-hodgkin lymphoma, marginal zone lymphoma